ATYRaTyr Pharma Inc. Common Stock
0.5015USD-5.87%Mkt Cap: 49.19M $P/E: —3d ago
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the Uni…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap49.19M $
Enterprise Value3.02M $
Revenue (TTM)190.00K $
Gross Profit-59.95M $
Net Income (TTM)-74.12M $
Revenue/Share0.0020 USD
Last Price0.5015 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees58
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.08
PEG—
EV/EBITDA-0.05
EV/Revenue15.92
P/S259.67
P/B1.01
EPS (TTM)-0.59
EPS (Forward)-0.46
52W Range
0.39502% of range6.500
52W High6.500 USD
52W Low0.3950 USD
Profitability
Gross Margin0.00%
Oper. Margin-33609.47%
EBITDA Margin0.00%
Profit Margin-39009.47%
ROE-109.84%
ROA-79.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-61.99M $
CapEx (TTM)77.00K $
FCF Margin-16688.55%
FCF Yield-64.46%
Net Debt-46.12M $
Net Debt/EBITDA0.73
Balance Sheet
Debt/Equity0.18
Current Ratio5.12
Quick Ratio5.08
Book Value/Sh0.4970 USD
Cash/Share0.5850 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateJul 1, 2019
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.857 USD
Upside (mean)+469.7%
Target Range1.000 USD – 7.000 USD
$1.000+469.7% to mean$7.000
# Analysts7
Ownership
Shares Out.98.09M
Float95.55M
Insiders2.45%
Institutions39.85%
Short Interest
Short Ratio7.1d
Short % Float11.42%
Short % Out.9.92%
Shares Short9.73M
Short (prev mo.)14.51M
Technical
SMA 500.5194 (-3.4%)
SMA 2000.7099 (-29.4%)
Beta0.52
S&P 52W Chg18.16%
Avg Vol (30d)965.93K
Avg Vol (10d)640.62K
Technical Indicators
RSI (14)45.7
MACD0.0022
MACD Signal0.0004
MACD Hist.+0.0018
BB Upper0.5625 USD
BB Middle0.5118 USD
BB Lower0.4611 USD
BB Width19.81%
ATR (14)0.0389 USD
Vol Ratio (20d)0.72x